1Chen XP, Qiu FZ, Wu ZD, et al. Chinese experience with hepatectomy forhuge hepatocellular carcinoma. Br J Surg, 2004, 91 (3) :322-326.
2Ohata K, Hamasaki K, Toriyama K, et al. Highviral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Gastroenterol Hepatol, 2004, 19 (6) : 670-675.
3Pal J, Somogyi C, Szmolenszky AA. Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primaryhepatocellular carcinomas using anti-HBxAg monoclonal antibody. Pathol Oncol Res, 2001, 7(3) : 178-184.
4Kubo S, Nishikawa M, Hirohashi K, et al. Multicentric occurrence of hepatocellular carcinoma in patients with a somatic mutation of mitochondorial DNA and hepatitis C virus. Hepatol Res, 2003, 25(1) : 78-82.
5Nakashima O, Kojiro M. Recurrence of hepatocellular carcinoma:multicentric occurrence or intrahepatic metastasis? A riewpoint in term of pathology. Hepatobiliary Pancreat Surg, 2001, 8(5) : 404-409.
6Tanaka A, Takeda R, Mukaihara S, et al. Treatment of ruptured hepatocellular carcinoma. Int J Clin Oncol, 2001, 6(6) : 291-295.
7Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma.Hepatology, 1997, 25(1) : 87-92.
8Sugimoto R, Okuda K, Tanaka M, et al. Metachronous multicentric occurence of hepatocellular carcinoma after surgical treatment.Clinic-opathological comparison with recurrence due to metastasis.Oncol Rep, 1999, 6(6) : 1303-1308.
9Arii S, Yamaoka Y, Fatagawa S, et al. Results of surgical and nonsurgical treatment for small-sized, hepatocellular carcinoma a retropective and natronuide survey in Japan. Hepatology, 2000,32(6) : 1224-1229.
10Maki A, Matsuda M, Asakawa M, et al. Decreased CD3 zeta molecules of T lymphocytes from patients with hepatocellular carcinoma associated with hepatitis C virus. Hepatol Res, 2003, 27(4) :272-278.
